Effects of PCSK9 inhibitor evolocumab on preventing early neurological deterioration in acute ischemic stroke patients with or without large artery atherosclerosis: a subgroup analysis of a randomized trial

Abstract Background Our previous study has demonstrated the preventive effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor on early neurological deterioration (END) in patients with acute non-cardiogenic ischemic stroke. Here, we performed a post hoc subgroup analysis to inves...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiahui Liu, Ying Li, Wen Tian, Hua Cao, Xidan Li, Liyuan Cheng, Xiaofei Ji, Jing Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-10-01
Colecção:	BMC Neurology
Assuntos:	Acute ischemic stroke Early neurological deterioration PCSK9 inhibitor Evolocumab Large artery atherosclerosis Inflammation
Acesso em linha:	https://doi.org/10.1186/s12883-025-04434-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!